# Aprepitant Effects on Oxycodone Response

> **NCT00999544** · NA · COMPLETED · sponsor: **Sharon Walsh** · enrollment: 9 (actual)

## Conditions studied

- Narcotic Abuse

## Interventions

- **DRUG:** Aprepitant 0mg
- **DRUG:** Aprepitant 40mg
- **DRUG:** Aprepitant 200mg
- **DRUG:** Oxycodone 0mg, p.o.
- **DRUG:** Oxycodone 20mg, p.o.
- **DRUG:** Oxycodone 40mg, p.o.
- **DRUG:** Oxycodone 0mg, IN
- **DRUG:** Oxycodone 15mg, IN
- **DRUG:** Oxycodone 30mg, IN

## Key facts

- **NCT ID:** NCT00999544
- **Lead sponsor:** Sharon Walsh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2017-09-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00999544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00999544, "Aprepitant Effects on Oxycodone Response". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00999544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*